Acosta J, Johnson G, Gould S, Dong K, Lendner Y, Detres D
bioRxiv. 2025; .
PMID: 40060482
PMC: 11888363.
DOI: 10.1101/2025.02.23.639770.
Brucher B
J Healthc Leadersh. 2025; 17:23-43.
PMID: 40007855
PMC: 11853952.
DOI: 10.2147/JHL.S506767.
Filipek-Gorzala J, Kwiecinska P, Szade A, Szade K
Front Oncol. 2024; 14:1308709.
PMID: 38440231
PMC: 10910019.
DOI: 10.3389/fonc.2024.1308709.
Stanger B, Wahl G
Annu Rev Pathol. 2023; 19:397-421.
PMID: 37832945
PMC: 11486542.
DOI: 10.1146/annurev-pathmechdis-031621-025610.
Ma Q, Zhao M, Long B, Li H
Commun Biol. 2023; 6(1):622.
PMID: 37296281
PMC: 10256737.
DOI: 10.1038/s42003-023-04973-1.
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory.
Artusa V, Calabrone L, Mortara L, Peri F, Bruno A
Int J Mol Sci. 2023; 24(5).
PMID: 36902427
PMC: 10003410.
DOI: 10.3390/ijms24054997.
Pre-clinical models for evaluating glioma targeted immunotherapies.
Frederico S, Zhang X, Hu B, Kohanbash G
Front Immunol. 2023; 13:1092399.
PMID: 36700223
PMC: 9870312.
DOI: 10.3389/fimmu.2022.1092399.
Cancer resistance to immunotherapy: What is the role of cancer stem cells?.
Gupta G, Merhej G, Saravanan S, Chen H
Cancer Drug Resist. 2023; 5(4):981-994.
PMID: 36627890
PMC: 9771758.
DOI: 10.20517/cdr.2022.19.
Potential to Eradicate Cancer Stemness by Targeting Cell Surface GRP78.
Chen H, Cheng A
Biomolecules. 2022; 12(7).
PMID: 35883497
PMC: 9313351.
DOI: 10.3390/biom12070941.
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.
Krause W
Cancer Drug Resist. 2022; 2(1):82-106.
PMID: 35582143
PMC: 9019178.
DOI: 10.20517/cdr.2019.06.
Regulatory RNAs, microRNA, long-non coding RNA and circular RNA roles in colorectal cancer stem cells.
Chao H, Wang T, Chern E, Hsu S
World J Gastrointest Oncol. 2022; 14(4):748-764.
PMID: 35582099
PMC: 9048531.
DOI: 10.4251/wjgo.v14.i4.748.
Role of p38 MAP kinase in cancer stem cells and metastasis.
Kudaravalli S, den Hollander P, Mani S
Oncogene. 2022; 41(23):3177-3185.
PMID: 35501462
PMC: 9166676.
DOI: 10.1038/s41388-022-02329-3.
Tumor collection/processing under physioxia uncovers highly relevant signaling networks and drug sensitivity.
Kumar B, Adebayo A, Prasad M, Capitano M, Wang R, Bhat-Nakshatri P
Sci Adv. 2022; 8(2):eabh3375.
PMID: 35020422
PMC: 8754301.
DOI: 10.1126/sciadv.abh3375.
Knockdown of zinc finger protein 267 suppresses diffuse large B-cell lymphoma progression, metastasis, and cancer stem cell properties.
Yang H, Wang L, Zheng Y, Hu G, Ma H, Shen L
Bioengineered. 2022; 13(1):1686-1701.
PMID: 35001816
PMC: 8805851.
DOI: 10.1080/21655979.2021.2014644.
Targeting Cancer Stem Cells-A Renewed Therapeutic Paradigm.
Amey C, Karnoub A
Oncol Hematol Rev. 2021; 13(1):45-55.
PMID: 33959299
PMC: 8098671.
DOI: 10.17925/ohr.2017.13.01.45.
Differentiation of Tumorigenic C6 Glioma Cells Induced by Enhanced IL-6 Signaling.
Chu I, Pan R, Yang C
Medicina (Kaunas). 2020; 56(11).
PMID: 33227992
PMC: 7699282.
DOI: 10.3390/medicina56110625.
Pre-clinical tumor models of primary brain tumors: Challenges and opportunities.
Akter F, Simon B, de Boer N, Redjal N, Wakimoto H, Shah K
Biochim Biophys Acta Rev Cancer. 2020; 1875(1):188458.
PMID: 33148506
PMC: 7856042.
DOI: 10.1016/j.bbcan.2020.188458.
CD44+/EPCAM+ cells detect a subpopulation of ALDH cells in human non-small cell lung cancer: A chance for targeting cancer stem cells?.
Masciale V, Grisendi G, Banchelli F, DAmico R, Maiorana A, Sighinolfi P
Oncotarget. 2020; 11(17):1545-1555.
PMID: 32391123
PMC: 7197447.
DOI: 10.18632/oncotarget.27568.
Gastrointestinal cancer stem cells as targets for innovative immunotherapy.
Chivu-Economescu M, Necula L, Matei L, Dragu D, Neagu A, Alexiu I
World J Gastroenterol. 2020; 26(14):1580-1593.
PMID: 32327907
PMC: 7167409.
DOI: 10.3748/wjg.v26.i14.1580.
PI3K/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma.
Chen J, Ge X, Zhang W, Ding P, Du Y, Wang Q
Theranostics. 2020; 10(7):3151-3163.
PMID: 32194860
PMC: 7053184.
DOI: 10.7150/thno.41362.